mRNA-mediated delivery of gene editing tools to human primary muscle stem cells
Muscular dystrophies are approximately 50 devastating, untreatable monogenic diseases leading to progressive muscle degeneration and atrophy. Gene correction of transplantable cells using CRISPR/Cas9-based tools is a realistic scenario for autologous cell replacement therapies to restore organ funct...
Saved in:
Main Authors: | Christian Stadelmann (Author), Silvia Di Francescantonio (Author), Andreas Marg (Author), Stefanie Müthel (Author), Simone Spuler (Author), Helena Escobar (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cas9-induced single cut enables highly efficient and template-free repair of a muscular dystrophy causing founder mutation
by: Stefanie Müthel, et al.
Published: (2023) -
Full-length Dysferlin Transfer by the Hyperactive Sleeping Beauty Transposase Restores Dysferlin-deficient Muscle
by: Helena Escobar, et al.
Published: (2016) -
mRNA as a Therapeutics: Understanding mRNA Vaccines
by: Ferdi Oğuz, et al.
Published: (2022) -
Filamin A pre-mRNA editing modulates vascularization and tumor growth
by: Mamta Jain, et al.
Published: (2022) -
Cell-Penetrating Peptides: Emerging Tools for mRNA Delivery
by: Hidetomo Yokoo, et al.
Published: (2021)